ProMetic Life Sciences Inc. | Mutual Funds
Mutual Funds that own ProMetic Life Sciences Inc.
Vanguard Total International Stock Index Fund
9,188,612
1.52%
0
0%
07/31/2018
Government Pension Fund - Global (The)
4,129,861
0.68%
-6,056
0%
12/31/2017
Vanguard Developed Markets Index Fund
3,754,210
0.62%
0
0%
07/31/2018
British Columbia Inv Management Corp.
2,765,605
0.46%
-474,595
0%
03/31/2017
BMO Canadian Large Cap Equity Fund
2,270,300
0.38%
-180,400
0.13%
12/31/2017
Vanguard FTSE All World (ex-US) Small Cap
1,683,584
0.28%
0
0.01%
07/31/2018
TD Emerald Canadian Equity Index Fund
1,543,100
0.26%
-14,800
0.02%
12/31/2017
Desjardins Quebec Balanced Fund
1,428,276
0.24%
34,436
0.15%
04/30/2018
CREF Stock Account
1,146,454
0.19%
778,341
0%
03/31/2018
Phillips Hager & North Canadian Growth Fund
1,128,500
0.19%
262,800
0.11%
12/31/2017
| Address |
440 Armand-Frappier Boulevard
Laval Québec H7V 4B4
Canada
|
|
Employees
|
- |
| Website |
http://www.prometic.com |
| Updated |
07/04/2019 |
| Prometic Life Sciences, Inc. engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation, and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment is involved in large-scale purification of biologics and the elimination of pathogens. |
